Mandate

Vinge advises Com Hem in connection with its application for listing on NASDAQ OMX Stockholm

June 03, 2014


Following the announcement of its intention to float on May 23, 2014, Com Hem Holding AB (publ) (“Com Hem”), a leading provider of TV, broadband and fixed telephony services in Sweden, has today published a prospectus and announced the price range for the initial public offering of its shares and its listing on NASDAQ OMX Stockholm. Vinge advises Com Hem in connection with the listing.
 
The Company will raise gross proceeds of up to SEK 6.24 billion in the initial public offering.
 
Vinge’s team primarily consists of partners Peter Bäärnhielm and Jesper Schönbeck and associates David Andersson, Joakim Hagberg, Sabina Börjesson, Charlotta Järnstedt and Tora Hansjons.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026